Trial Profile

A Phase I Clinical Study of PTC 518 in healthy volunteer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Votoplam (Primary)
Indications Huntington's disease
Focus Adverse reactions; First in man
Sponsors PTC Therapeutics

Most Recent Events

10 Jan 2022 Status changed from recruiting to completed, according to a PTC Therapeutics media release.
20 Sep 2021 According to a PTC Therapeutics media release, the company to host a conference call on Sept. 23, 2021 to discuss results form this trial and provide an update on phase 2 trial.
29 Jul 2021 According to a PTC Therapeutics media release, results from additional cohorts are expected from the Phase 1 healthy volunteer trial of PTC518 for Huntington's disease in the third quarter of this year.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com